title: Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism. A systematic review.
authors.forename: E
authors.initials: E
authors.lastname: Gándara
authors.forename: M
authors.initials: M
authors.lastname: Carrier
authors.affiliation: Dr. Marc Rodger, Thrombosis Program, Ottawa Hospital-Ottawa Hospital Research Institute, General Campus-Centre for Practice Changing Research, 501 Smyth Road, Rm L2265e, Box 201A, Ottawa, Ontario K1H 8L6, Canada, Tel.: +1 613 737 8899 ext 79084, Fax: +1 613 739 6102, E-mail: mrodger@ohri.ca.
authors.forename: M A
authors.initials: MA
authors.lastname: Rodger
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D054796:Drug Dosage Calculations; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D013997:Time Factors; D054556:Venous Thromboembolism / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight